Interleukin-1β and cancer
C Rébé, F Ghiringhelli - Cancers, 2020 - mdpi.com
… dichotomous effects of IL-1, without differentiating between IL-1β and IL-1α. … IL-1β was
underlined by studies using deficient mice or anti-IL-1 antibody, suggesting that IL-1β in the tumor …
underlined by studies using deficient mice or anti-IL-1 antibody, suggesting that IL-1β in the tumor …
IL-6 in inflammation, autoimmunity and cancer
T Hirano - International immunology, 2021 - academic.oup.com
… Non-immune and immune cells, cytokines such as IL-1β, IL-6 and tumor necrosis factor alpha
(… roles of IL-6 and the local initiation model in inflammation, autoimmunity and cancer are …
(… roles of IL-6 and the local initiation model in inflammation, autoimmunity and cancer are …
[HTML][HTML] The role of interleukins in colorectal cancer
J Li, L Huang, H Zhao, Y Yan, J Lu - International journal of …, 2020 - ncbi.nlm.nih.gov
… cancer therapy. Herein, we divide currently known interleukins into 6 families, including IL-1
family, IL-2 family… -21 was broadly reported to be an essential proinflammatory mediator and …
family, IL-2 family… -21 was broadly reported to be an essential proinflammatory mediator and …
Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer
… as interleukin-1, interleukin-6, interleukin-10, tumor necrosis … factor-β are involved in tumor
initiation and progression. Thus… IL-6 and TNF-α synergistically mediate EMT progression via …
initiation and progression. Thus… IL-6 and TNF-α synergistically mediate EMT progression via …
Targeting interleukin-1β and inflammation in lung cancer
J Zhang, N Veeramachaneni - Biomarker research, 2022 - Springer
… main mediators in the IL-1 family are the agonistic ligands IL-1α and IL-1β, with the antagonistic
ligand IL-1 receptor antagonist (IL-1RA) binding to the same receptor, IL-1R [15]. Both …
ligand IL-1 receptor antagonist (IL-1RA) binding to the same receptor, IL-1R [15]. Both …
Inflammation and tumor progression: signaling pathways and targeted intervention
H Zhao, L Wu, G Yan, Y Chen, M Zhou… - Signal transduction and …, 2021 - nature.com
… mediators (SPM), have been identified as pivotal regulators of the initiation and resolution of
inflammation. … developed to specifically modulate inflammation in cancer therapy, with some …
inflammation. … developed to specifically modulate inflammation in cancer therapy, with some …
The role of interleukin 1β in the pathogenesis of lung cancer
EB Garon, JCH Yang, SM Dubinett - JTO clinical and research reports, 2020 - Elsevier
… IL-1β activity and lung cancer development and provide the basis for targeting IL-1β in lung
cancer … IL-1β is a key mediator in the initiation of the inflammatory response in pulmonary …
cancer … IL-1β is a key mediator in the initiation of the inflammatory response in pulmonary …
The interplay among miRNAs, major cytokines, and cancer-related inflammation
C Chakraborty, AR Sharma, G Sharma… - Molecular Therapy-Nucleic …, 2020 - cell.com
… and is an indispensable component that orchestrates the tumor microenvironment. Studies
suggest that different mediator and cellular effectors, including cytokines (interleukins, tumor …
suggest that different mediator and cellular effectors, including cytokines (interleukins, tumor …
Interplay between inflammation and cancer
… tumors inflammatory cytokines like Interleukin-6 (IL-6) is highly increased and appreciable
level of IL… cells and produce inflammatory mediators, which eventually can cause cancers. …
level of IL… cells and produce inflammatory mediators, which eventually can cause cancers. …
Targeting inflammatory pathways in cardiovascular disease: the inflammasome, interleukin-1, interleukin-6 and beyond
P Libby - Cells, 2021 - mdpi.com
… Inhibition of TNF can impair tumor surveillance and predispose to … of IL-1, but also of other
downstream mediators that it triggers, both protein and lipid. These mediators induced by IL-1 …
downstream mediators that it triggers, both protein and lipid. These mediators induced by IL-1 …